These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16514081)

  • 1. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
    King VL; Trivedi DB; Gitlin JM; Loftin CD
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1137-43. PubMed ID: 16514081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice.
    Gitlin JM; Trivedi DB; Langenbach R; Loftin CD
    Cardiovasc Res; 2007 Jan; 73(1):227-36. PubMed ID: 17137566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-2 in cardiovascular disease.
    Bishop-Bailey D; Mitchell JA; Warner TD
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):956-8. PubMed ID: 16627818
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype.
    Mukherjee K; Gitlin JM; Loftin CD
    J Cardiovasc Pharmacol; 2012 Dec; 60(6):520-9. PubMed ID: 22967986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice.
    Martin-McNulty B; Tham DM; da Cunha V; Ho JJ; Wilson DW; Rutledge JC; Deng GG; Vergona R; Sullivan ME; Wang YX
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1627-32. PubMed ID: 12855485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice.
    Cao RY; Adams MA; Habenicht AJ; Funk CD
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):34-42. PubMed ID: 17643886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
    Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
    Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD; Zeng ZR; Hu PJ
    Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
    Jacob S; Laury-Kleintop L; Lanza-Jacoby S
    J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI.
    Turner GH; Olzinski AR; Bernard RE; Aravindhan K; Karr HW; Mirabile RC; Willette RN; Gough PJ; Jucker BM
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):220-6. PubMed ID: 19808546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats.
    Batu OS; Erol K
    Inflammopharmacology; 2007 Dec; 15(6):260-5. PubMed ID: 18236017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA; Duffy A; Toomey S; Fitzgerald DJ
    Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone reduces the development and rupture of experimental aortic aneurysms.
    Jones A; Deb R; Torsney E; Howe F; Dunkley M; Gnaneswaran Y; Gaze D; Nasr H; Loftus IM; Thompson MM; Cockerill GW
    Circulation; 2009 Jun; 119(24):3125-32. PubMed ID: 19506106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibition attenuates abdominal aortic aneurysm progression in hyperlipidemic mice.
    Ghoshal S; Loftin CD
    PLoS One; 2012; 7(11):e44369. PubMed ID: 23209546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice.
    Yamanouchi D; Morgan S; Kato K; Lengfeld J; Zhang F; Liu B
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):702-7. PubMed ID: 20075419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway.
    Miyamoto K; Miyake S; Mizuno M; Oka N; Kusunoki S; Yamamura T
    Brain; 2006 Aug; 129(Pt 8):1984-92. PubMed ID: 16835249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice.
    Wormser U; Langenbach R; Peddada S; Sintov A; Brodsky B; Nyska A
    Toxicol Appl Pharmacol; 2004 Oct; 200(1):40-7. PubMed ID: 15451306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib.
    Hinz B; Dormann H; Brune K
    Arthritis Rheum; 2006 Jan; 54(1):282-91. PubMed ID: 16385545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 expression in chondrosarcoma: a role for celecoxib treatment?
    Schrage YM; Machado I; Meijer D; Briaire-de Bruijn I; van den Akker BE; Taminiau AH; Kalinski T; Llombart-Bosch A; Bovée JV
    Eur J Cancer; 2010 Feb; 46(3):616-24. PubMed ID: 20004565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice.
    Stolle K; Berges A; Lietz M; Lebrun S; Wallerath T
    Toxicol Lett; 2010 Dec; 199(3):403-9. PubMed ID: 20937366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.